Palvella Therapeutics (PVLA) said Nasdaq approved the transfer of its common stock listing from the Nasdaq Capital Market to the Nasdaq Global Market, effective May 13. – The companyâs shares will continue trading under the ticker âPVLA.â – CEO Wes Kaupinen said
Palvella Therapeutics Approved for Transfer to Nasdaq Global Market
Palvella Therapeutics (PVLA) said Nasdaq approved the transfer of its common stock listing from the Nasdaq Capital Market to the Nasdaq Global Market, effective May 13. - The companyâs shares will continue trading under the ticker âPVLA.â - CEO Wes Kaupinen said